275 related articles for article (PubMed ID: 26183398)
1. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
[TBL] [Abstract][Full Text] [Related]
2. Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1.
Kaiser FJ; Tavassoli K; Van den Bemd GJ; Chang GT; Horsthemke B; Möröy T; Lüdecke HJ
Hum Mol Genet; 2003 Jun; 12(11):1349-58. PubMed ID: 12761050
[TBL] [Abstract][Full Text] [Related]
3. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
[TBL] [Abstract][Full Text] [Related]
5. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
[TBL] [Abstract][Full Text] [Related]
6. The RING finger protein RNF4, a co-regulator of transcription, interacts with the TRPS1 transcription factor.
Kaiser FJ; Möröy T; Chang GT; Horsthemke B; Lüdecke HJ
J Biol Chem; 2003 Oct; 278(40):38780-5. PubMed ID: 12885770
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1.
Malik TH; Shoichet SA; Latham P; Kroll TG; Peters LL; Shivdasani RA
EMBO J; 2001 Apr; 20(7):1715-25. PubMed ID: 11285235
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
9. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
Piscopo DM; Johansen EB; Derynck R
J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
[TBL] [Abstract][Full Text] [Related]
10. A central role for TRPS1 in the control of cell cycle and cancer development.
Wu L; Wang Y; Liu Y; Yu S; Xie H; Shi X; Qin S; Ma F; Tan TZ; Thiery JP; Chen L
Oncotarget; 2014 Sep; 5(17):7677-90. PubMed ID: 25277197
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation modulates transcriptional repression by TRPS1.
Kaiser FJ; Lüdecke HJ; Weger S
Biol Chem; 2007 Apr; 388(4):381-90. PubMed ID: 17391059
[TBL] [Abstract][Full Text] [Related]
12. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?
Masson O; Bach AS; Derocq D; Prébois C; Laurent-Matha V; Pattingre S; Liaudet-Coopman E
Biochimie; 2010 Nov; 92(11):1635-43. PubMed ID: 20493920
[TBL] [Abstract][Full Text] [Related]
14. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.
Serandour AA; Mohammed H; Miremadi A; Mulder KW; Carroll JS
Oncogene; 2018 Sep; 37(39):5281-5291. PubMed ID: 29895970
[TBL] [Abstract][Full Text] [Related]
15. TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
Sci Signal; 2011 Jun; 4(177):ra41. PubMed ID: 21673316
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
17. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
18. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
Elster D; Tollot M; Schlegelmilch K; Ori A; Rosenwald A; Sahai E; von Eyss B
Nat Commun; 2018 Aug; 9(1):3115. PubMed ID: 30082728
[TBL] [Abstract][Full Text] [Related]
19. TRPS1 drives heterochromatic origin refiring and cancer genome evolution.
Yang J; Liu X; Huang Y; He L; Zhang W; Ren J; Wang Y; Wu J; Wu X; Shan L; Yang X; Sun L; Liang J; Zhang Y; Shang Y
Cell Rep; 2021 Mar; 34(10):108814. PubMed ID: 33691114
[TBL] [Abstract][Full Text] [Related]
20. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter.
Xing W; Archer TK
Mol Endocrinol; 1998 Sep; 12(9):1310-21. PubMed ID: 9731700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
